Skip to content

Cohort Study of Metabolic Disease and Hypertension

Metabolic Disease and Hypertension in Adults: A Prospective Cohort Study (Phase One)

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07577063
Enrollment
2500
Registered
2026-05-11
Start date
2026-06-01
Completion date
2031-12-01
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension (HTN), Type 2 Diabetes Mellitus (T2DM)

Keywords

Type 2 Diabetes Mellitus, Hypertension, Cardiometabolic risk, Obesity, Prediabetes, Prehypertension

Brief summary

The goal of this observational study is to learn how type 2 diabetes and high blood pressure develop over time in adults in Mexico. The study will include men and women between 18 and 65 years of age who do not have a previous diagnosis of these conditions. The main questions this study aims to answer are: What factors increase the risk of developing type 2 diabetes? What factors increase the risk of developing high blood pressure? Participants will not receive any experimental treatment. Researchers will observe their health as part of their regular medical care. Participants will: Attend an initial visit that includes physical measurements, blood tests, and questionnaires about their health, lifestyle, and environment Perform a simple walking test to measure physical fitness Return once a year for follow-up visits over a period of five years During the study, researchers will monitor participants to identify new cases of type 2 diabetes and high blood pressure. The results of this study may help improve prevention strategies and support public health programs aimed at reducing chronic diseases in Mexico.

Detailed description

This prospective dynamic cohort study includes repeated annual measurements to evaluate temporal changes in cardiometabolic exposures and their relationship with incident outcomes. Data will be collected using standardized procedures and electronic case report forms captured via a tablet-based system. Information will be recorded in the digital platform of the MIDO ecosystem, developed by the Carlos Slim Health Institute, and subsequently safeguarded by the Mexican Social Security Institute (IMSS) in accordance with applicable regulations on research and personal data protection. The database will be preserved for at least 10 years, ensuring confidentiality and appropriate use of the information. Measurements include anthropometric assessments, blood pressure, biochemical testing, and structured instruments for lifestyle, physical fitness, and social and environmental determinants. Physical fitness will be assessed using the six-minute walk test. Data management will include internal consistency checks, identification of outliers, and assessment of missing data. When appropriate, imputation methods and sensitivity analyses will be applied. Participants will be followed longitudinally, allowing evaluation of changes in exposures and their association with outcomes. Statistical analysis will include multivariable models and dimensionality reduction techniques, such as principal component analysis, to identify patterns among risk factors.

Interventions

OTHERObservational Study

Participants are observed over time without receiving any experimental intervention. Data are collected as part of routine clinical assessments and scheduled follow-up visits.

Sponsors

Coordinación de Investigación en Salud, Mexico
Lead SponsorOTHER_GOV
Secretaria de Salud, Mexico
CollaboratorOTHER_GOV
Instituto Mexicano del Seguro Social
CollaboratorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 to 65 years * No prior diagnosis of type 2 diabetes mellitus or hypertension * Receiving care at primary health care units of the Mexican Social Security Institute (IMSS) or IMSS-Bienestar * Willing and able to provide informed consent * Willing to participate in baseline and annual follow-up assessments

Exclusion criteria

* Prior diagnosis of type 2 diabetes mellitus or hypertension * Pregnancy at the time of enrollment * Any condition that limits the ability to perform study procedures, including the six-minute walk test * Any condition that, in the opinion of the investigators, may interfere with participation or follow-up

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Type 2 Diabetes MellitusUp to 5 yearsNew cases of type 2 diabetes mellitus identified during follow-up based on clinical diagnosis, laboratory criteria (fasting glucose or HbA1c), or medical records.
Incidence of HypertensionUp to 5 yearsNew cases of hypertension identified during follow-up based on blood pressure measurements, clinical diagnosis, or medical records.

Secondary

MeasureTime frameDescription
Association Between Diet Quality and Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsAssessment of dietary quality and its association with the development of metabolic outcomes during follow-up.
Association Between Changes in Body Weight, Body Composition, and Dyslipidemia With Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsAssessment of the association between longitudinal changes in body weight, body composition, and dyslipidemia and the incidence of type 2 diabetes mellitus and hypertension during the follow-up period.
Association Between Physical Activity Level and Sedentary Behavior With Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsAssessment of the association between physical activity level and sedentary behavior and the incidence of type 2 diabetes mellitus and hypertension during the follow-up period.
Association Between Physical Fitness Measured by the Six-Minute Walk Test and Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsAssessment of the association between physical fitness measured by the six-minute walk test and the incidence of type 2 diabetes mellitus and hypertension during the follow-up period.
Association Between Family History of Type 2 Diabetes Mellitus and Hypertension and Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsAssessment of the association between family history of type 2 diabetes mellitus and hypertension and the incidence of these conditions during the follow-up period.
Time to Development of Type 2 Diabetes Mellitus in Participants With Prediabetes at BaselineUp to 5 yearsTime from baseline to diagnosis of type 2 diabetes mellitus among participants with prediabetes, based on standard clinical criteria during the follow-up period.
Time to Development of Hypertension in Participants With Prehypertension at BaselineUp to 5 yearsTime from baseline to diagnosis of hypertension among participants with prehypertension, based on standard clinical criteria during the follow-up period.
Latent Structures of Social and Environmental Determinants and Their Association With Incident Type 2 Diabetes Mellitus and HypertensionUp to 5 yearsIdentification of latent structures of social and environmental determinants using principal component analysis and assessment of their association with the incidence of type 2 diabetes mellitus and hypertension during the follow-up period.

Countries

Mexico

Contacts

CONTACTRodolfo Rivas Ruiz, PhD
rodolfo.rivasr@imss.gob.mx+52 5556276900
PRINCIPAL_INVESTIGATORRodolfo Rivas, PhD

Instituto Mexicano del Seguro Social

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026